文献速递骨软组织肉瘤与黑色素瘤

通过专科门诊对黑色素瘤高风险患者进行皮肤监测的成本效益

Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.
PubMed 文献 · J Clin Oncol · 2016-10-28

本研究基于决策分析模型,比较澳大利亚悉尼高风险专科门诊的专科监测与标准诊疗在10年内的成本与效益。结果显示专科监测更便宜且更有效,人均节省6828澳元,人均质量调整生命年增加0.31,可疑病变年均切除率更低,敏感性分析结果稳健。

要点

  • 专科监测较标准诊疗人均节省6828澳元(95%CI 5564至8092),人均增加0.31质量调整生命年(95%CI 0.27至0.35)。
  • 专科监测可疑病变年均切除率为0.81(95%CI 0.72至0.91),低于标准诊疗的2.55(95%CI 2.34至2.76)。
  • 差异主要驱动因素为黑色素瘤更早期发现从而治疗强度更低,敏感性分析结果稳健。

核心结论

  • 专科监测是管理黑色素瘤高风险个体的成本效益策略,且较社区标准诊疗侵入性操作更少。

研究设计与样本

  • 构建决策分析模型,从卫生系统视角比较专科监测与标准诊疗10年内的成本与效益。
  • 高风险标准诊疗队列来自Sax研究所45 and Up队列研究链接Medicare Benefits Schedule索赔数据、癌症登记和住院数据。
  • 效益以质量调整生命年增加衡量,并对所有模型参数进行敏感性分析。

主要发现

  • 专科监测较标准诊疗人均节省6828澳元(95%CI 5564至8092),人均质量调整生命年增加0.31(95%CI 0.27至0.35)。
  • 专科监测可疑病变年均切除率为0.81(95%CI 0.72至0.91),标准诊疗为2.55(95%CI 2.34至2.76)。
  • 差异主要驱动因素为黑色素瘤更早期发现导致治疗强度更低,以及专科监测可疑病变年均切除率更低。
  • 敏感性分析中结果稳健。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Clinical guidelines recommend that people at high risk of melanoma receive regular surveillance to improve survival through early detection. A specialized High Risk Clinic in Sydney, Australia was found to be effective for this purpose; however, wider implementation of this clinical service requires evidence of cost-effectiveness and data addressing potential overtreatment of suspicious skin lesions. Patients and Methods A decision-analytic model was built to compare the costs and benefits of specialized surveillance compared with standard care over a 10-year period, from a health system perspective. A high-risk standard care cohort was obtained using linked population data, comprising the Sax Institute's 45 and Up cohort study, linked to Medicare Benefits Schedule claims data, the cancer registry, and hospital admissions data. Benefits were measured in quality-adjusted life-years gained. Sensitivity analyses were undertaken for all model parameters. Results Specialized surveillance through the High Risk Clinic was both less expensive and more effective than standard care. The mean saving was A$6,828 (95% CI, $5,564 to $8,092) per patient, and the mean quality-adjusted life-year gain was 0.31 (95% CI, 0.27 to 0.35). The main drivers of the differences were detection of melanoma at an earlier stage resulting in less extensive treatment and a lower annual mean excision rate for suspicious lesions in specialized surveillance (0.81; 95% CI, 0.72 to 0.91) compared with standard care (2.55; 95% CI, 2.34 to 2.76). The results were robust when tested in sensitivity analyses. Conclusion Specialized surveillance was a cost-effective strategy for the management of individuals at high risk of melanoma. There were also fewer invasive procedures in specialized surveillance compared with standard care in the community.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Watts CG, Cust AE, Menzies SW, et al. Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma. J Clin Oncol. 2016. PMID: 28034073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。